Zobrazeno 1 - 10 of 42 pro vyhledávání: '"Vils SR"'
1
Akademický článek
Revaccination of patients with systemic lupus erythematosus or rheumatoid arthritis without an initial COVID-19 vaccine response elicits seroconversion in half of the patients.
Autor: Ammitzbøll C; Department of Rheumatology, Aarhus University Hospital, and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. chramm@rm.dk., Thomsen MK; Department of Clinical Medicine, Aarhus University, and Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark., Andersen JB; Department of Rheumatology, Horsens Regional Hospital, Horsens, Denmark., Jensen JMB; Department of Clinical Immunology, Aarhus University Hospital, and Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., Bayarri-Olmos R; Department of Clinical Immunology section 7631, Rigshospitalet, University Hospital of Copenhagen, Denmark., Garred P; Department of Clinical Immunology section 7631, Rigshospitalet, University Hospital of Copenhagen, Denmark., Hermansen MF; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark., Johannsen AD; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark., Larsen ML; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark., Mistegaard CE; Department of Rheumatology, Aarhus University Hospital; Department of Clinical Medicine, Aarhus University, and Department of Biomedicine, Aarhus University, Aarhus, Denmark., Mikkelsen S; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark., Nielsen L; Department of Infectious Diseases, Aarhus University, Aarhus, Denmark., Olesen R; Department of Infectious Diseases, Aarhus University, Aarhus, Denmark., Pérez-Alós L; Department of Clinical Immunology section 7631, Rigshospitalet, University Hospital of Copenhagen, Denmark., Vils SR; Department of Rheumatology, Aarhus University Hospital, and Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., Szabados F; Department of Rheumatology, Hjørring Hospital, Hjørring, Denmark., Søgaard OS; Department of Infectious Diseases, Aarhus University, Aarhus, Denmark., Tolstrup M; Department of Infectious Diseases, Aarhus University, Aarhus, Denmark., Erikstrup C; Department of Clinical Medicine, Aarhus University, and Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark., Hauge EM; Department of Rheumatology, Aarhus University Hospital, and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Troldborg A; Department of Rheumatology, Aarhus University Hospital, and Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Publikováno v: Clinical and experimental rheumatology [Clin Exp Rheumatol] 2024 Jan; Vol. 42 (1), pp. 157-165. Date of Electronic Publication: 2023 Oct 23.
Zobrazit plný text záznamu
2
Akademický článek
Rituximab-treated rheumatic patients: B cells predict seroconversion after COVID-19 boost or revaccination in initial vaccine non-responders.
Autor: Ammitzbøll C; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Kragh Thomsen M; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark., Bøgh Andersen J; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark., Jensen JMB; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., From Hermansen ML; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark., Dahl Johannsen A; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark., Larsen ML; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark., Mistegaard CE; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Mikkelsen S; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark., Szabados F; Department of Rheumatology, Hjørring Hospital, Hjørring, Denmark., Vils SR; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Erikstrup C; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark., Hauge EM; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Troldborg A; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.; Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2023 Jul 05; Vol. 62 (7), pp. 2544-2549.
Zobrazit plný text záznamu
3
Akademický článek
COVID-19 vaccination in patients with rheumatic diseases leads to a high seroconversion rate and reduced self-imposed isolation and shielding behaviour.
Autor: Ammitzbøll C; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Thomsen MK; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark., Andersen JB; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark., Bartels LE; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark., Hermansen MF; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark., Johannsen AD; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark., Mistegaard CE; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Mikkelsen S; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark., Vils SR; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Erikstrup C; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark., Hauge EM; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Troldborg A; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Publikováno v: Modern rheumatology [Mod Rheumatol] 2023 Jul 04; Vol. 33 (4), pp. 777-785.
Zobrazit plný text záznamu
4
Akademický článek
Platelets and the Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus or Antiphospholipid Syndrome.
Autor: Vils SR; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Troldborg A; Department of Biomedicine, Aarhus University, Aarhus, Denmark.; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark., Hvas AM; Faculty of Health, Aarhus University, Aarhus, Denmark.; Thrombosis and Haemostasis Research Unit, Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark., Thiel S; Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Publikováno v: TH open : companion journal to thrombosis and haemostasis [TH Open] 2023 Jun 15; Vol. 7 (2), pp. e155-e167. Date of Electronic Publication: 2023 Jun 15 (Print Publication: 2023).
Zobrazit plný text záznamu
5
Akademický článek
Isolation, Behavioral Changes, and Low Seroprevalence of SARS-CoV-2 Antibodies in Patients With Systemic Lupus Erythematosus or Rheumatoid Arthritis.
Autor: Ammitzbøll C; Aarhus University Hospital, Aarhus, Denmark., Andersen JB; Aarhus University Hospital, Aarhus, Denmark., Vils SR; Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Mistegaard CE; Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Mikkelsen S; Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Erikstrup C; Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Thomsen MK; Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Hauge EM; Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Troldborg A; Aarhus University and Aarhus University Hospital, Aarhus, Denmark.
Publikováno v: Arthritis care & research [Arthritis Care Res (Hoboken)] 2022 Nov; Vol. 74 (11), pp. 1780-1785. Date of Electronic Publication: 2022 Aug 04.
Zobrazit plný text záznamu
6
Akademický článek
Time Since Rituximab Treatment Is Essential for Developing a Humoral Response to COVID-19 mRNA Vaccines in Patients With Rheumatic Diseases.
Autor: Troldborg A; A. Troldborg, MD, PhD, Department of Rheumatology, Aarhus University Hospital, Department of Biomedicine, and Department of Clinical Medicine, Aarhus University; annetrol@rm.dk., Thomsen MK; M.K. Thomsen, MD, Department of Clinical Medicine, Aarhus University, and Department of Clinical Microbiology, Aarhus University Hospital., Bartels LE; L.E. Bartels, MD, PhD, J.B. Andersen, MD, A.D. Johannsen, MD, M.L.F. Hermansen, MD, PhD, Department of Rheumatology, Aarhus University Hospital., Andersen JB; L.E. Bartels, MD, PhD, J.B. Andersen, MD, A.D. Johannsen, MD, M.L.F. Hermansen, MD, PhD, Department of Rheumatology, Aarhus University Hospital., Vils SR; S.R. Vils MS, Department of Rheumatology, Aarhus University Hospital, and Department of Biomedicine, Aarhus University., Mistegaard CE; C.E. Mistegaard, MD, Department of Rheumatology, and Department of Clinical Microbiology, Aarhus University Hospital, and Department of Biomedicine, Aarhus University., Johannsen AD; L.E. Bartels, MD, PhD, J.B. Andersen, MD, A.D. Johannsen, MD, M.L.F. Hermansen, MD, PhD, Department of Rheumatology, Aarhus University Hospital., Hermansen MF; L.E. Bartels, MD, PhD, J.B. Andersen, MD, A.D. Johannsen, MD, M.L.F. Hermansen, MD, PhD, Department of Rheumatology, Aarhus University Hospital., Mikkelsen S; S. Mikkelsen, MD, Department of Clinical Immunology, Aarhus University Hospital., Erikstrup C; C. Erikstrup, MD, PhD, Department of Clinical Medicine, Aarhus University, and Department of Clinical Immunology, Aarhus University Hospital., Hauge EM; E.M. Hauge, MD, PhD, C. Ammitzbøll, MD, PhD, Department of Rheumatology, Aarhus University Hospital, and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Ammitzbøll C; E.M. Hauge, MD, PhD, C. Ammitzbøll, MD, PhD, Department of Rheumatology, Aarhus University Hospital, and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Publikováno v: The Journal of rheumatology [J Rheumatol] 2022 Jun; Vol. 49 (6), pp. 644-649. Date of Electronic Publication: 2022 Mar 01.
Zobrazit plný text záznamu
7
Akademický článek
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.
Autor: Bartels LE; Department of Rheumatology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 59, Entrance E, 8200, Aarhus, Denmark., Ammitzbøll C; Department of Rheumatology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 59, Entrance E, 8200, Aarhus, Denmark. chramm@rm.dk.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. chramm@rm.dk., Andersen JB; Department of Rheumatology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 59, Entrance E, 8200, Aarhus, Denmark., Vils SR; Department of Rheumatology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 59, Entrance E, 8200, Aarhus, Denmark.; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Mistegaard CE; Department of Rheumatology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 59, Entrance E, 8200, Aarhus, Denmark.; Department of Biomedicine, Aarhus University, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Johannsen AD; Department of Rheumatology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 59, Entrance E, 8200, Aarhus, Denmark., Hermansen MF; Department of Rheumatology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 59, Entrance E, 8200, Aarhus, Denmark., Thomsen MK; Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Erikstrup C; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Hauge EM; Department of Rheumatology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 59, Entrance E, 8200, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Troldborg A; Department of Rheumatology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 59, Entrance E, 8200, Aarhus, Denmark.; Department of Biomedicine, Aarhus University, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Publikováno v: Rheumatology international [Rheumatol Int] 2021 Nov; Vol. 41 (11), pp. 1925-1931. Date of Electronic Publication: 2021 Sep 02.
Zobrazit plný text záznamu
8
Akademický článek
Safety, efficacy, and immunogenicity of SARS-CoV-2 mRNA vaccination in children and adult patients with rheumatic diseases: a comprehensive literature review.
Autor: Dhanasekaran P; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. mdcpd@nus.edu.sg., Karasu BT; Division of Rheumatology, Department of Medicine, University Medicine Cluster, National University Health System, Singapore, Singapore., Mak A; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Division of Rheumatology, Department of Medicine, University Medicine Cluster, National University Health System, Singapore, Singapore.
Publikováno v: Rheumatology international [Rheumatol Int] 2024 Dec; Vol. 44 (12), pp. 2757-2794. Date of Electronic Publication: 2024 Nov 22.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje